Apiban 2.5 mg tablet is a medicine made by NIPRO JMI Pharma Ltd. It is further used in the treatment of deep vein thrombosis.
There are 16 brands of Apixaban listed in Bangladesh. 2 of them have a lower unit price than Apiban. The lowest listed price is Antixa 2.5 mg Tablet at ৳ 10.00 per unit.
What is Apiban 2.5 mg Tablet?
The tablet Apiban contains Apixaban and is made by NIPRO JMI Pharma Ltd. It is used to lower the risk of stroke in people with an irregular heartbeat called nonvalvular atrial fibrillation, to prevent clots after hip or knee replacement surgery, and to treat deep vein thrombosis. Whether it suits you is a decision for your doctor.
Uses of Apiban
It is further used in the treatment of deep vein thrombosis. Apiban is used in adults for a few specific clot-related problems. It is also used to help prevent deep vein thrombosis, which can lead to pulmonary embolism, in people who have had hip or knee replacement surgery. The doctor decides whether this medicine is suitable and will determine the correct dose and course for each patient.
How to use Apiban
Take Apiban exactly as your doctor tells you. Apiban is taken by mouth. Swallow the tablet with water. Do not stop taking this medicine without talking to your doctor first, as stopping suddenly can increase the risk of blood clots.
Side effects of Apiban
Apiban can cause side effects. A skin rash or a severe allergic reaction can also occur. Watch for signs such as unusual bruising, nosebleeds, bleeding gums, or blood in urine or stool. Ask your doctor or pharmacist for a full list of possible side effects and how to recognise them. Tell your doctor promptly about unusual or prolonged bleeding, or any rash or allergic symptoms.
Safety and precautions
Do not use Apiban if you have active pathological bleeding or have had a severe allergic reaction to Apixaban. There is limited information on its use in pregnancy and breastfeeding. It is unknown whether it passes into breast milk, so breastfeeding mothers should ask their doctor. Do not stop this medicine without medical advice, as doing so can raise the risk of stroke or other clots.
Frequently asked questions
What does Apiban treat?
It is further used in the treatment of deep vein thrombosis. Apiban is used in adults for a few specific clot-related problems.
How should I take Apiban?
Take Apiban exactly as your doctor tells you. Apiban is taken by mouth.
What should I watch for while using Apiban?
Apiban can cause side effects. A skin rash or a severe allergic reaction can also occur.
To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery
... Read more
Apixaban is a factor Xa inhibitor indicated:
To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery
For the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy
Pharmacology
Apixaban acts by inhibiting coagulation, and thus prevents development of blood clots. As a result of FXa inhibition, apixaban prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastin time (aPTT). Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of apixaban.
Dosage & Administration
Recommended Dose: The recommended dose of Apixaban for most patients is 5 mg taken orally twice daily.
Dosage Adjustments: The recommended dose of Apixaban is 2.5 mg twice daily in patients with any 2 of the following characteristics: age ≥80 years, body weight ≤60 kg, serum creatinine ≥1.5mg/dl.
CYP3A4 and P-gp inhibitors: When Apixaban is coadministered with drugs that are strong dual inhibitors of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) (e.g. ketoconazole, itraconazole, ritonavir, clarithromycin) the recommended dose is 2.5 mg twice daily.
Missed Dose: If a dose of Apixaban is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-daily administration should be resumed. The dose should not be doubled to make up for a missed dose.
Discontinuation for Surgery and Other Interventions: Apixaban should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding. Apixaban should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where the bleeding would be non-critical in location and easily controlled.
Switching from or to Apixaban: Switching from warfarin to Apixaban: Warfarin should be discontinued and Apixaban started when the international normalized ratio (INR) is below 2.0.
Switching from Apixaban to warfarin: Apixaban affects INR, so that INR measurements during co-administration with warfarin may not be useful for determining the appropriate dose of warfarin. If continuous anticoagulation is necessary, discontinue Apixaban and begin both a parenteral anticoagulant and warfarin at the time the next dose of Apixaban would have been taken, discontinuing the parenteral anticoagulant when INR reaches an acceptable range.
Switching between Apixaban and anticoagulants other than warfarin: Discontinue one being taken and begin the other at the next scheduled dose.
Interaction
Apixaban is a substrate of both CYP3A4 and P-gp. Inhibitors of CYP3A4 and P-gp increase exposure to Apixaban and increase the risk of bleeding. Inducers of CYP3A4 and P-gp decrease exposure to Apixaban and increase the risk of stroke.
Contraindications
Apixaban is contraindicated in patients with the following conditions: Active pathological bleeding. Severe hypersensitivity reaction to Apixaban (i.e. anaphylactic reactions).
Side Effects
Apixaban can cause a skin rash or severe allergic reaction.
Pregnancy & Lactation
Pregnancy: There are no adequate and well-controlled studies of Apixaban in pregnant women. Treatment is likely to increase the risk of hemorrhage during pregnancy and delivery. Apixaban should be used during pregnancy only if the potential benefit outweighs the potential risk to the mother and fetus.
Labor and Delivery: Safety and effectiveness of Apixaban during labor and delivery have not been studied in clinical trials. Consider the risks of bleeding and of stroke in using Apixaban in this condition.
Nursing Mothers: It is unknown whether Apixaban or its metabolites are excreted in human milk. Women should be instructed either to discontinue breastfeeding or to discontinue Apixaban therapy, taking into account the importance of the drug to the mother.
Precautions & Warnings
Increased Risk of Stroke with Discontinuation of Apixaban Discontinuing Apixaban in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. An increased rate of stroke was observed during the transition from Apixaban to warfarin in clinical trials in patients with nonvalvular atrial fibrillation. If Apixaban must be discontinued for a reason other than pathological bleeding, consider coverage with another anticoagulant.
Overdose Effects
There is no antidote to Apixaban. Overdose of Apixaban increases the risk of bleeding. Activated charcoal may be useful in the management of Apixaban overdose.
Storage Conditions
Keep in a dry place and store below 30°C. Protect from light and keep out of the reach of children.
Alternative brands of Apixaban
Other brands with the same generic name, cheapest first.